# Combination Study of Prexasertib and Olaparib in Patients With Advanced Solid Tumors

> **NCT03057145** · PHASE1 · COMPLETED · sponsor: **Geoffrey Shapiro, MD, PhD** · enrollment: 29 (actual)

## Conditions studied

- Solid Tumor

## Interventions

- **DRUG:** Prexasertib
- **DRUG:** Olaparib

## Key facts

- **NCT ID:** NCT03057145
- **Lead sponsor:** Geoffrey Shapiro, MD, PhD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-10
- **Primary completion:** 2020-02-25
- **Final completion:** 2021-06-09
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2021-09-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03057145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03057145, "Combination Study of Prexasertib and Olaparib in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03057145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*